Jeremy Bender
2020
In 2020, Jeremy Bender earned a total compensation of $2.8M as Chief Executive Officer and President at Day One Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $56,356 |
|---|---|
| Salary | $141,667 |
| Stock Awards | $2,555,158 |
| Total | $2,753,181 |
Bender received $2.6M in stock awards, accounting for 93% of the total pay in 2020.
Bender also received $56.4K in non-equity incentive plan and $141.7K in salary.
Rankings
In 2020, Jeremy Bender's compensation ranked 4,189th out of 13,090 executives tracked by ExecPay. In other words, Bender earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,189 out of 13,090 | 68th |
Division Manufacturing | 1,691 out of 5,621 | 70th |
Major group Chemicals And Allied Products | 650 out of 2,254 | 71st |
Industry group Drugs | 556 out of 1,954 | 72nd |
Industry Pharmaceutical Preparations | 423 out of 1,459 | 71st |
Source: SEC filing on April 28, 2022.
Bender's colleagues
We found one more compensation record of an executive who worked with Jeremy Bender at Day One Biopharmaceuticals in 2020.
2020
Samuel Blackman
Day One Biopharmaceuticals